Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.


  • Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
  • William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
  • Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
  • Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of
  • Gardiner Harris science reporter for "The New York Times"

Topics + Tags


comments powered by Disqus
Most Recent Shows

Friday News Roundup – International

Friday, Oct 21 2016The Islamic State launches a counterattack in the Iraqi city of Kirkuk, as the battle to retake Mosul intensifies. Ecuador cuts off Internet access to WikiLeaks founder Julian Assange. And the president of the Philippines says his country is pivoting away from the U.S. A panel of journalists joins guest host Derek McGinty for analysis of the week's top international news stories.

Friday News Roundup – Domestic

Friday, Oct 21 2016In the final debate, Donald Trump refuses to say whether he’ll accept the election results. North Carolina officials investigate the firebombing of Republican Party headquarters. And a police chiefs’ organization apologizes for ‘historical mistreatment of minorities.’ A panel of journalists joins guest host Derek McGinty for analysis of the week's top national news stories.